van der Stelt M et al. |
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. |
2005 |
FASEB J. |
pmid:15894565
|
Lambert DM and Fowler CJ |
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. |
2005 |
J. Med. Chem. |
pmid:16078824
|
Venderova K et al. |
Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus. |
2005 |
Exp. Neurol. |
pmid:15899265
|
Gokoh M et al. |
2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells. |
2005 |
Biochem. J. |
pmid:15456404
|
Hohmann AG et al. |
An endocannabinoid mechanism for stress-induced analgesia. |
2005 |
Nature |
pmid:15973410
|
Harada N et al. |
Effects of cannabinoids on colonic muscle contractility and tension in guinea pigs. |
2005 |
J Nippon Med Sch |
pmid:15834207
|
Oka S et al. |
Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear. |
2005 |
J. Biol. Chem. |
pmid:15749716
|
Kishimoto S et al. |
Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells. |
2005 |
J. Biochem. |
pmid:15749836
|
Julien B et al. |
Antifibrogenic role of the cannabinoid receptor CB2 in the liver. |
2005 |
Gastroenterology |
pmid:15765409
|
Kaplan BL et al. |
2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2. |
2005 |
J. Leukoc. Biol. |
pmid:15774549
|
Chen J et al. |
Finding of endocannabinoids in human eye tissues: implications for glaucoma. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:15823551
|
Hill MN et al. |
Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala. |
2005 |
Eur. J. Pharmacol. |
pmid:16324692
|
Straiker A and Mackie K |
Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. |
2005 |
J. Physiol. (Lond.) |
pmid:16179366
|
Maccarrone M et al. |
Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. |
2005 |
Mol. Hum. Reprod. |
pmid:15563449
|
Shoemaker JL et al. |
Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:16081674
|
Sipe JC et al. |
Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. |
2005 |
J. Leukoc. Biol. |
pmid:15845647
|
Jung KM et al. |
Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. |
2005 |
Mol. Pharmacol. |
pmid:16051747
|
Makara JK et al. |
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. |
2005 |
Nat. Neurosci. |
pmid:16116451
|
Secko D |
Analgesia through endogenous cannabinoids. |
2005 |
CMAJ |
pmid:16103504
|
Maejima T et al. |
Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum. |
2005 |
J. Neurosci. |
pmid:16033892
|
Panikashvili D et al. |
CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition. |
2005 |
J. Cereb. Blood Flow Metab. |
pmid:15729296
|
Gopez JJ et al. |
Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury. |
2005 |
Neurosurgery |
pmid:15730585
|
Zhao Q et al. |
2-Arachidonoylglycerol stimulates activator protein-1-dependent transcriptional activity and enhances epidermal growth factor-induced cell transformation in JB6 P+ cells. |
2005 |
J. Biol. Chem. |
pmid:15886210
|
Rouzer CA and Marnett LJ |
Glycerylprostaglandin synthesis by resident peritoneal macrophages in response to a zymosan stimulus. |
2005 |
J. Biol. Chem. |
pmid:15917246
|
Nithipatikom K et al. |
A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:15919052
|
Darmani NA et al. |
Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew. |
2005 |
Neuropharmacology |
pmid:15921709
|
Kola B et al. |
Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. |
2005 |
J. Biol. Chem. |
pmid:15899896
|
Shoemaker JL et al. |
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15901805
|
Saario SM et al. |
Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. |
2005 |
Chem. Biol. |
pmid:15975510
|
Gauthier KM et al. |
Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15528233
|
Gabbay E et al. |
Endocannabinoids and liver disease--review. |
2005 |
Liver Int. |
pmid:16162147
|
Vandevoorde S et al. |
Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:16181610
|
Ramos JA et al. |
Therapeutic potential of the endocannabinoid system in the brain. |
2005 |
Mini Rev Med Chem |
pmid:16026307
|
Wahn H et al. |
The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:16055511
|
Kurabayashi M et al. |
2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver. |
2005 Jan-Feb |
J Invest Surg |
pmid:15804949
|
Rockwell CE et al. |
Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. |
2006 |
Mol. Pharmacol. |
pmid:16611855
|
Szabo B et al. |
Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. |
2006 |
J. Physiol. (Lond.) |
pmid:16973696
|
Kasai HF et al. |
Studies on high-energy collision-induced dissociation of endogenous cannabinoids: 2-arachidonoylglycerol and n-arachidonoylethanolamide in FAB-mass spectrometry. |
2006 |
Anal Sci |
pmid:16837740
|
Mechoulam R et al. |
Endocannabinoids, feeding and suckling--from our perspective. |
2006 |
Int J Obes (Lond) |
pmid:16570101
|
Matias I et al. |
Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. |
2006 |
Int J Obes (Lond) |
pmid:16570107
|
Waku K |
[Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol]. |
2006 |
Yakugaku Zasshi |
pmid:16462096
|
Guagnini F et al. |
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P. |
2006 |
Gut |
pmid:16423891
|
Bari M et al. |
New insights into endocannabinoid degradation and its therapeutic potential. |
2006 |
Mini Rev Med Chem |
pmid:16515464
|
Matias I et al. |
Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. |
2006 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:17011761
|
Bari M et al. |
Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells. |
2006 |
J. Immunol. |
pmid:17015679
|
Spoto B et al. |
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol. |
2006 |
Biochimie |
pmid:16949718
|
Gough NR |
Focus issue: signaling lipids. |
2006 |
Sci. STKE |
pmid:16467192
|
Wagner JA et al. |
2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts. |
2006 |
J. Cardiovasc. Pharmacol. |
pmid:16775503
|
Quistad GB et al. |
Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice. |
2006 |
Toxicol. Appl. Pharmacol. |
pmid:16310817
|
van der Stelt M et al. |
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. |
2006 |
Cell. Mol. Life Sci. |
pmid:16732431
|
Panikashvili D et al. |
The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. |
2006 |
Neurobiol. Dis. |
pmid:16364651
|
Parkkari T et al. |
Synthesis and CB1 receptor activities of dimethylheptyl derivatives of 2-arachidonoyl glycerol (2-AG) and 2-arachidonyl glyceryl ether (2-AGE). |
2006 |
Bioorg. Med. Chem. |
pmid:16403642
|
Avraham Y et al. |
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. |
2006 |
Neurobiol. Dis. |
pmid:16102970
|
D'Argenio G et al. |
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. |
2006 |
FASEB J. |
pmid:16403786
|
Suplita RL et al. |
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. |
2006 |
Neuropharmacology |
pmid:16316669
|
Juan-Picó P et al. |
Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell. |
2006 |
Cell Calcium |
pmid:16321437
|
Saario SM et al. |
URB754 has no effect on the hydrolysis or signaling capacity of 2-AG in the rat brain. |
2006 |
Chem. Biol. |
pmid:16931330
|
Sang N et al. |
PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons. |
2006 |
J. Physiol. (Lond.) |
pmid:16484297
|
Parkkari T et al. |
Alpha-methylated derivatives of 2-arachidonoyl glycerol: synthesis, CB1 receptor activity, and enzymatic stability. |
2006 |
Bioorg. Med. Chem. Lett. |
pmid:16466915
|
Kurihara R et al. |
Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils. |
2006 |
J. Biol. Chem. |
pmid:16513651
|
Mestre L et al. |
The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler's virus infection. |
2006 |
Biochem. Pharmacol. |
pmid:16914119
|
Blüher M et al. |
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. |
2006 |
Diabetes |
pmid:17065342
|
Oka S et al. |
Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice. |
2006 |
J. Immunol. |
pmid:17142782
|
Oka S et al. |
Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol. |
2006 |
Eur. J. Pharmacol. |
pmid:16647054
|
Melis M et al. |
Protective activation of the endocannabinoid system during ischemia in dopamine neurons. |
2006 |
Neurobiol. Dis. |
pmid:16762556
|
Malcher-Lopes R et al. |
Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. |
2006 |
J. Neurosci. |
pmid:16775153
|
Kishimoto S et al. |
Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants. |
2006 |
Int. Arch. Allergy Immunol. |
pmid:16772720
|
Hermann A et al. |
2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook. |
2006 |
AAPS J |
pmid:16808043
|
Yoshida T et al. |
Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. |
2006 |
J. Neurosci. |
pmid:16672646
|
Sugiura T et al. |
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2006 |
Prog. Lipid Res. |
pmid:16678907
|
Katona I et al. |
Molecular composition of the endocannabinoid system at glutamatergic synapses. |
2006 |
J. Neurosci. |
pmid:16723519
|
Shiga N et al. |
Elimination of 2-arachidonoylglycerol action by direct hemoperfusion through immobilized polymyxin B fibers: an experimental study in conscious guinea pigs. |
2006 |
Ther Apher Dial |
pmid:17199882
|
McCarron RM et al. |
Endothelial-mediated regulation of cerebral microcirculation. |
2006 |
J. Physiol. Pharmacol. |
pmid:17244945
|
Parrish JC and Nichols DE |
Serotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism. |
2006 |
J. Neurochem. |
pmid:17010161
|
Rubio M et al. |
Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. |
2007 |
Neurosci. Lett. |
pmid:17574742
|
Ryberg E et al. |
The orphan receptor GPR55 is a novel cannabinoid receptor. |
2007 |
Br. J. Pharmacol. |
pmid:17876302
|
Williams J et al. |
Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. |
2007 |
Anal. Chem. |
pmid:17600384
|
Centonze D et al. |
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. |
2007 |
Brain |
pmid:17626034
|
Adermark L and Lovinger DM |
Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step. |
2007 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:18077376
|
Béquet F et al. |
CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. |
2007 |
Eur. J. Neurosci. |
pmid:18052990
|
Siegmund SV et al. |
The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. |
2007 |
FASEB J. |
pmid:17440119
|
Uchigashima M et al. |
Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. |
2007 |
J. Neurosci. |
pmid:17409230
|
Lafourcade M et al. |
Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. |
2007 |
PLoS ONE |
pmid:17684555
|
Gokoh M et al. |
2-Arachidonoylglycerol enhances the phagocytosis of opsonized zymosan by HL-60 cells differentiated into macrophage-like cells. |
2007 |
Biol. Pharm. Bull. |
pmid:17603153
|
Cisneros JA et al. |
Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase. |
2007 |
J. Med. Chem. |
pmid:17764163
|
Degn M et al. |
Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice. |
2007 |
J. Neurochem. |
pmid:17868306
|
Sugiura T |
[2-Arachidonoylglycerol: an endogenous cannabinoid receptor ligand]. |
2007 |
Seikagaku |
pmid:17763698
|
Smid SD et al. |
The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon. |
2007 |
Eur. J. Pharmacol. |
pmid:17706636
|
He F et al. |
Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: a new role of Hsp-90 in migration signaling of a G protein-coupled receptor. |
2007 |
Mol. Pharmacol. |
pmid:17698952
|
Saario SM and Laitinen JT |
Monoglyceride lipase as an enzyme hydrolyzing 2-arachidonoylglycerol. |
2007 |
Chem. Biodivers. |
pmid:17712832
|
Ho WS and Randall MD |
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. |
2007 |
Br. J. Pharmacol. |
pmid:17245358
|
Vadivel SK et al. |
Conformationally constrained analogues of 2-arachidonoylglycerol. |
2007 |
Bioorg. Med. Chem. Lett. |
pmid:17826996
|
Blankman JL et al. |
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. |
2007 |
Chem. Biol. |
pmid:18096503
|
Guindon J et al. |
The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors. |
2007 |
Br. J. Pharmacol. |
pmid:17179944
|
Scutt A and Williamson EM |
Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors. |
2007 |
Calcif. Tissue Int. |
pmid:17205329
|
Imming P |
Fatty pain cures. |
2007 |
Chem. Biol. |
pmid:18096498
|
King AR et al. |
URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices. |
2007 |
Chem. Biol. |
pmid:18096504
|
Opitz CA et al. |
Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells. |
2007 |
FEBS Lett. |
pmid:17904123
|
Mukhopadhyay S and Tulis DA |
Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke. |
2007 |
Cardiovasc Hematol Agents Med Chem |
pmid:17979695
|
Dainese E et al. |
Modulation of the endocannabinoid system by lipid rafts. |
2007 |
Curr. Med. Chem. |
pmid:17979719
|